Kyle Robert Jaep

Experience: Venture Capital/Private Placements: $5,000,000 SAFE financing by blockchain.; $4,000,000 token purchase agreement and token warrant offering of blockchain company specializing in digital marketplace for anime content.; $2,000,000 simple agreement for future tokens (SAFT) financing by blockchain.; $50,000,000 cross-border corporate venture capital investment by leading Korean health care company into Series A venture financing of U.S. space and aeronautics company.; Aggregate $10,000,000 cross-border Series A venture capital investments by Singaporean fund into AI, health tech, and semiconductor IP licensing companies.; $3,000,000 conversion of SAFE held by corporate venture capital arm of leading automaker into Series B venture financing of technology company specializing in automaker software.; Aggregate $11,000,000 corporate venture capital investments by leading automaker in Series D venture financings of technology companies specializing in supply-chain networks.; $5,000,000 corporate venture capital investment by leading automaker in Series A venture financing of company specializing in self-driving automotive technology.; $2,500,000 corporate venture capital investment by leading automaker in Series B venture financing of technology company specializing in trucking industry.; $2,000,000 private placement of convertible notes of company specializing in wave semiconductor.; $1,500,000 private placement of convertible notes of company specializing in green market for carbon-tax credits.; $1,000,000 cross-border venture capital investment by Taiwanese electronics company in venture financing of AI imaging company.; $1,500,000 spinoff transaction by blockchain company of its; Aggregate $20,000,000 in private placements of convertible notes of public pharmaceutical company specializing in treatment of neurological disorders.; Aggregate $10,000,000 in private placements of common stock warrants of public pharmaceutical company specializing in treatment of neurological disorders.; Public Offerings: Cross-border de-SPAC transaction to result in listing of common stock and warrants of leading Zimbabwean gold mining company, valued at $500,000,000, on the Nasdaq Global Market.; Cross-border de-SPAC transaction to result in listing of common stock and warrants of leading Japanese chemical recycling company, valued at $300,000,000, on the NYSE (pending).; $19,000,000 cross-border IPO of common stock of a Japanese manufacturer of personal care products and spatial materials, led by Boustead Securities, LLC and Sutter Securities,, resulting in listing on the Nasdaq Capital Market.; Reverse takeover/merger transaction resulting in listing of common stock of medical technology company, valued at $110,000,000, on the Nasdaq Capital Market.; De-SPAC transaction resulting in listing of common stock and warrants of leading digital commerce platform for automotive aftermarket, valued at $250,000,000, on the NYSE American.; $140,000,000 at-the-market (ATM) offering program of leading provider of automotive LIDAR; $7,500,000 qualified offering under Regulation A of pharmaceutical company specializing in treatment of neurological disorders.; $2,000,000 equity line of credit of pharmaceutical company specializing in treatment of neurological; $525,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Barclays, Credit Suisse, and US Bancorp.; $450,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Credit Suisse, and US Bancorp.; $450,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Barclays, Credit Suisse, and US Bancorp.